Cosentyx sensoready 150 MG penml
Ended Awarded Last action
- Contract number
- SPE2DR26F39A5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,307
Award facts
- Contract value 100% obligated
- $13,307.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a $13,307.08 delivery order by the Defense Logistics Agency (DLA) on January 5, 2026, for the supply of Cosentyx SensoReady 150 mg pen/mL, a biologic medication used to treat inflammatory conditions. This is a firm fixed price, competitively awarded contract with no set-aside designation, with performance to be completed by January 6, 2026, and fulfillment occurring at the company's headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a broad portfolio of medications and medical commodities to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive contract awards with DLA demonstrate its capability to fulfill diverse pharmaceutical needs ranging from specialty biologics and brand-name medications to generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order represents one of numerous pharmaceutical transactions executed under the company's prime vendor agreement with DLA.
Quick answers
Who was awarded contract SPE2DR26F39A5?
SPE2DR26F39A5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F39A5 worth?
The government has obligated $13,307 on SPE2DR26F39A5.
Is contract SPE2DR26F39A5 an order under another contract?
Yes. SPE2DR26F39A5 is a delivery order under SPE2DR25D1051, an indefinite delivery contract.
Was contract SPE2DR26F39A5 competed?
The extent of competition for SPE2DR26F39A5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award